China: Market for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in China

The Chinese market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses expanded slightly to $X in 2023, growing by X% against the previous year. In general, consumption enjoyed a buoyant expansion. Over the period under review, the market attained the maximum level at $X in 2021; however, from 2022 to 2023, consumption remained at a lower figure.

Production of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in China

In value terms, production of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses rose slightly to $X in 2023 estimated in export price. Over the period under review, production enjoyed a prominent increase. The most prominent rate of growth was recorded in 2013 with an increase of X%. Production of peaked at $X in 2021; however, from 2022 to 2023, production failed to regain momentum.

Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses

Exports from China

Exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses from China fell to X tons in 2023, which is down by X% on 2022 figures. The total export volume increased at an average annual rate of X% over the period from 2012 to 2023; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth appeared the most rapid in 2020 with an increase of X%. As a result, the exports reached the peak of X tons. From 2021 to 2023, the growth of the exports of remained at a lower figure.

In value terms, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses reduced slightly to $X in 2023. Overall, exports, however, continue to indicate a prominent increase. The pace of growth appeared the most rapid in 2022 when exports increased by X% against the previous year. As a result, the exports attained the peak of $X, and then reduced modestly in the following year.

Exports by Country

The United States (X tons) was the main destination for exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses from China, accounting for a X% share of total exports. Moreover, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses to the United States exceeded the volume sent to the second major destination, India (X tons), threefold. Mexico (X tons) ranked third in terms of total exports with a X% share.

From 2012 to 2023, the average annual growth rate of volume to the United States totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: India (X% per year) and Mexico (X% per year).

In value terms, India ($X) remains the key foreign market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses exports from China, comprising X% of total exports. The second position in the ranking was held by the United States ($X), with a X% share of total exports. It was followed by Japan, with a X% share.

From 2012 to 2023, the average annual rate of growth in terms of value to India amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: the United States (X% per year) and Japan (X% per year).

Export Prices by Country

In 2023, the average export price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses amounted to $X per ton, rising by X% against the previous year. Overall, export price indicated a moderate expansion from 2012 to 2023: its price increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, export price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses increased by X% against 2020 indices. The pace of growth appeared the most rapid in 2021 when the average export price increased by X% against the previous year. The export price peaked in 2023 and is expected to retain growth in the near future.

There were significant differences in the average prices for the major external markets. In 2023, amid the top suppliers, the country with the highest price was India ($X per ton), while the average price for exports to the Philippines ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to Algeria (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses

Imports into China

For the fourth consecutive year, China recorded growth in purchases abroad of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses, which increased by X% to X tons in 2023. Overall, imports showed a significant increase. The most prominent rate of growth was recorded in 2021 when imports increased by X% against the previous year. Over the period under review, imports of attained the peak figure in 2023 and are likely to see gradual growth in years to come.

In value terms, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses expanded rapidly to $X in 2023. Over the period under review, imports saw a remarkable increase. The most prominent rate of growth was recorded in 2021 with an increase of X%. Imports peaked in 2023 and are expected to retain growth in years to come.

Imports by Country

France (X tons), Italy (X tons) and South Africa (X tons) were the main suppliers of imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses to China, together comprising X% of total imports. Slovenia, Japan, Austria, India, Belgium, Norway and Germany lagged somewhat behind, together comprising a further X%.

From 2012 to 2023, the biggest increases were recorded for Slovenia (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, France ($X), Italy ($X) and South Africa ($X) constituted the largest non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses suppliers to China, with a combined X% share of total imports. Belgium, Japan, Austria, Slovenia, Germany, India and Norway lagged somewhat behind, together accounting for a further X%.

Slovenia, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2023, the average import price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses amounted to $X per ton, which is down by X% against the previous year. In general, the import price faced a abrupt descent. The pace of growth appeared the most rapid in 2017 an increase of X% against the previous year. As a result, import price attained the peak level of $X per ton. From 2018 to 2023, the average import prices remained at a somewhat lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2023, amid the top importers, the country with the highest price was Belgium ($X per ton), while the price for India ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by France (X%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform